Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9S92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,803
Award facts
- Contract value 100% obligated
- $14,803.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,803.14 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 29, 2025, with completion targeted for December 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor within the federal medical procurement ecosystem.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle supports pharmaceutical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide, enabling the company to supply a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities. The DLA's strategic approach includes plans to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts with several contractors, underscoring AmerisourceBergen's role as one of the military's primary pharmaceutical suppliers.
Quick answers
Who was awarded contract SPE2DR26F9S92?
SPE2DR26F9S92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F9S92 worth?
The government has obligated $14,803 on SPE2DR26F9S92.
Is contract SPE2DR26F9S92 an order under another contract?
Yes. SPE2DR26F9S92 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9S92 competed?
The extent of competition for SPE2DR26F9S92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award